McNatty K P, Hudson N L, Heath D A, Shaw L, Blay L, Berry L, Lun S
Wallaceville Animal Research Centre, Upper Hutt, New Zealand.
J Endocrinol. 1993 Aug;138(2):315-25. doi: 10.1677/joe.0.1380315.
This study in ewes examined the effects on ovarian function of a pulsatile regimen of ovine FSH (NIADDK-oFSH-17) administered over a 24- to 28-day period beginning on day 1 of the oestrous cycle (day 0 = oestrus). The FSH (1.66 micrograms or 5.00 micrograms) was administered i.v. over a 1-min interval once every hour throughout the treatment period. In other ewes ovine LH (NIDDK-oLH-23) was administered (10 micrograms once every 2 h) for 24-28 days together with oFSH (1.66 micrograms/h). Compared with untreated controls (n = 19 ewes), FSH alone at both doses (n = 10 ewes/dose) as well as the FSH + LH treatment (n = 10) led to significant increases in the plasma concentrations of FSH (P < 0.01), ovarian weight (P < 0.05) and ovulation rate (P < 0.01) but there was no change in the mean weight of individual corpora lutea (CL). Exogenous FSH at the high but not the low dose alone or with LH stimulated a significant overall increase in plasma inhibin concentrations (P < 0.05). The geometric mean (and 95% confidence limits) ovulation rates in the high FSH (i.e. 5.00 micrograms/h), low FSH (i.e. 1.66 micrograms/h), low FSH + LH, and control treatment groups were 15.3 (9.3, 24.8), 3.7 (2.1, 6.0), 3.7 (2.5, 5.8) and 1.4 (1.2, 1.7) respectively. The FSH or FSH + LH treatments did not alter the total numbers of antral follicles (> or = 1 mm diameter). However, the high but not the low FSH or low FSH + LH treatment led to significant increases in the mean numbers of large follicles (i.e. > 4.5 mm diameter; P < 0.01) and a higher proportion of non-atretic antral follicles. Highly significant linear relationships were found between the mean plasma concentrations of FSH or inhibin and the ovulation rate (FSH: r = 0.74, P < 0.0001; inhibin: r = 0.93, P < 0.0001). Highly significant linear relationships were also found between the plasma concentrations of FSH or inhibin and the number of large follicles (i.e. > 4.5 mm diameter; FSH, r = 0.78, P < 0.0001; inhibin, r = 0.80, P < 0.0001) and between the plasma concentrations of inhibin and the number of granulosa cells in large follicles (r = 0.78, P < 0.0001). After the high FSH but not the low FSH treatment there were significant increases in both FSH- and LH-induced responsiveness in granulosa cells with respect to cyclic AMP synthesis in vitro.(ABSTRACT TRUNCATED AT 400 WORDS)
本研究以母羊为对象,在发情周期的第1天(第0天=发情期)开始的24至28天内,研究了脉冲式注射绵羊促卵泡素(NIADDK - oFSH - 17)对卵巢功能的影响。在整个治疗期间,促卵泡素(1.66微克或5.00微克)以每小时1次、每次1分钟的间隔静脉注射。在其他母羊中,绵羊促黄体素(NIDDK - oLH - 23)(每2小时10微克)与促卵泡素(1.66微克/小时)一起注射24至28天。与未治疗的对照组(19只母羊)相比,两种剂量的单独促卵泡素组(每组10只母羊)以及促卵泡素+促黄体素治疗组(10只)的促卵泡素血浆浓度(P<0.01)、卵巢重量(P<0.05)和排卵率(P<0.01)均显著增加,但单个黄体的平均重量没有变化。单独使用高剂量而非低剂量的外源性促卵泡素或与促黄体素联合使用时,刺激血浆抑制素浓度显著总体升高(P<0.05)。高促卵泡素组(即5.00微克/小时)、低促卵泡素组(即1.66微克/小时)、低促卵泡素+促黄体素组和对照组的几何平均(及95%置信限)排卵率分别为15.3(9.3,24.8)、3.7(2.1,6.0)、3.7(2.5,5.8)和1.4(1.2,1.7)。促卵泡素或促卵泡素+促黄体素治疗并未改变窦状卵泡(直径≥1毫米)的总数。然而,高促卵泡素组而非低促卵泡素组或低促卵泡素+促黄体素组导致大卵泡(即直径>4.5毫米)的平均数量显著增加(P<0.01),且非闭锁窦状卵泡的比例更高。促卵泡素或抑制素的平均血浆浓度与排卵率之间存在高度显著的线性关系(促卵泡素:r = 0.74,P<0.0001;抑制素:r = 0.93,P<0.0001)。促卵泡素或抑制素的血浆浓度与大卵泡数量(即直径>4.5毫米)之间以及抑制素的血浆浓度与大卵泡颗粒细胞数量之间也存在高度显著的线性关系(促卵泡素,r = 0.78,P<0.0001;抑制素,r = 0.80,P<0.0001);抑制素与大卵泡颗粒细胞数量之间(r = 0.78,P<0.0001)。高促卵泡素组而非低促卵泡素组治疗后,颗粒细胞对促卵泡素和促黄体素诱导的体外环磷酸腺苷合成反应显著增加。(摘要截断于400字)